Demeed Pharmaceutical

Our Products & Formulation Services

At Demeed Pharmaceutical, our product portfolio is built around one speciality: modified-release pellet technology. We develop and manufacture a comprehensive range of pellet-based drug delivery systems — engineered for precision, validated for compliance, and delivered in Ready-to-Fill form. Every product we offer is the result of deep formulation science, API-specific expertise, and a manufacturing process designed for rigour and repeatability. Below is a detailed overview of our core product categories.

01. Modified Release (MR) Pellets

Modified release pellets are the cornerstone of our portfolio. These systems are engineered to release an API at a controlled rate over an extended period — achieving once-daily or twice-daily therapeutic coverage with a single capsule dose.

Therapeutic Applications:

  • Cardiovascular — Metoprolol Succinate ER, Diltiazem HCl ER, Propranolol HCl MR
  • CNS — Memantine HCl ER, Donepezil HCl MR, Duloxetine HCl DR
  • GI — Esomeprazole MR, Lansoprazole DR

 

Key Benefits:

  • Precise control of drug release rate and duration
  • Reduced dosing frequency and improved patient compliance
  • Consistent dissolution profiles batch-to-batch
  • Customisable release targets to match your clinical requirements
  • Available in Ready-to-Fill capsule format

02. Retard Micro Granules

Our Retard Micro Granules are precision-coated granule systems designed for APIs requiring delayed, sustained, or pulsatile drug release. The retard coating is applied with exacting process controls to ensure membrane integrity and dissolution reproducibility.

Ideal For:

  • APIs with a narrow therapeutic index requiring controlled release
  • Formulations targeting sustained plasma levels over 12–24 hours
  • Products requiring multi-phasic release (immediate + delayed release)

Key Benefits:

  • Precisely controlled coating thickness for reproducible release
  • Excellent acid resistance and membrane stability
  • Scalable from pilot to commercial batch sizes
  • Comprehensive dissolution and stability data provided

03. Enteric-Coated (EC) Pellets

For APIs that are acid-labile or require targeted intestinal delivery, our enteric-coated pellet systems provide reliable gastric protection and defined dissolution onset in the intestinal environment.

API Examples:

  • Esomeprazole Magnesium EC Pellets
  • Lansoprazole EC Pellets
  • Other proton pump inhibitors and acid-sensitive molecules

Key Benefits:

  • Robust gastric acid resistance (pH < 2 for 2 hours)
  • Rapid and complete dissolution at intestinal pH
  • High API content uniformity across the pellet batch
  • Stable under accelerated and long-term ICH conditions

04. Combination Blend Systems

Some of the most clinically effective therapies involve two or more active ingredients delivered in a single dosage form. Our combination pellet blends are engineered to co-encapsulate multiple APIs — each with its own release profile — in a single Ready-to-Fill capsule system.

Current Combination Systems:

  • Aspirin + Dipyridamole — Immediate + Extended Release Pellet Blend
  • Tamsulosin HCl + Dutasteride — Modified Release Combination Capsule Fill

 

Key Benefits:

  • Independent release profiles for each API within the same capsule
  • Engineered for API compatibility and physical stability
  • Reduces pill burden and improves patient adherence
  • Custom combination blends developed on enquiry

05. Fenofibrate (Nano) DC Granules

Fenofibrate presents significant bioavailability challenges owing to its poor aqueous solubility. Our Nano DC (Direct Compression) Granule technology addresses this by reducing particle size to the nanometre range — dramatically improving dissolution rate and bioavailability.

Key Features:

  • Nanosized API particles for enhanced surface area and dissolution
  • Direct compression-compatible granule format
  • Reproducible particle size distribution and dissolution performance
  • Suitable for both tablet and capsule formulation platforms

 

Key Benefits:

  • Significantly improved bioavailability versus conventional micronised grades
  • Reduced food effect variability
  • Well-characterised with robust analytical data

06. Ready-to-Fill Capsule Systems

All of our pellet products are available in Ready-to-Fill (RTF) form — pre-formulated and quality-released pellet blends that can be directly encapsulated into hard gelatin or HPMC capsules at your facility.

Why Ready-to-Fill?

  • Eliminates the need for an in-house pelletisation capability
  • Reduces process validation burden at your site
  • Faster product launch — no formulation development stage required
  • Consistent quality from a dedicated, validated manufacturer
  • Supported by complete quality documentation for regulatory use